The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output.
Abstract
The present study examined whether a prolonged infusion of tumor necrosis factor (TNF) into rats could sustain the increased rate of whole body glucose metabolism observed with short term exposure, and whether TNF produced hepatic or peripheral insulin resistance. Basal glucose metabolism was determined with the use of [3-3H]glucose 18 h after initiating a constant infusion of recombinant human TNF (1 microgram/kg.h). Thereafter, a two-step euglycemic hyperinsulinemic clamp was performed to determine whether TNF impaired insulin action. The overnight infusion of TNF minimally elevated plasma glucose concentrations (17%), but produced large increases in the whole body rate of glucose production and utilization (133%). Under hyperinsulinemic conditions, the glucose infusion rate necessary to maintain euglycemia was 30% lower in TNF-treated rats, indicating an insulin-resistant condition. This resulted from an impaired ability of insulin to both suppress hepatic glucose production and stimulate peripheral glucose utilization in TNF-infused animals. A second series of experiments was performed, using the in vivo tracer [U-14C]2-deoxyglucose technique, to elucidate which tissues were responsible for the TNF-induced increase in basal (no exogenous insulin) glucose disposal and peripheral insulin resistance. Under basal conditions, TNF increased glucose uptake by various muscles (gastrocnemius, heart, and diaphragm) as well as nonmuscle tissues (liver, lung, spleen, gut, skin and fat). Because of their relatively large mass and/or high rate of glucose uptake, the increased uptake by skin (25%), intestine (24%), muscle (23%), and liver (15%) accounted for the majority of the TNF-induced increment in whole body glucose disposal. Under euglycemic hyperinsulinemic conditions, the increment in glucose uptake by muscle and skin (85%) accounted for the majority of the glucose disposal in control rats. However, in TNF-infused animals, hyperinsulinemia failed to increase glucose uptake by skin and blunted the insulin-mediated increase in muscle by 73%. These results suggest that sustained elevations of TNF during chronic therapy and prolonged production of TNF by patients and experimental animals with malignancies or infectious diseases may be an important mechanism for the enhanced glucose flux as well as the insulin resistance seen in these conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast to such distributions, there are reports that IL-6 and TNF-a seem to be equally synthesised by the different sites (28,36,53 -59) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [28]
In the citing paper
“Thus, leptin is preferentially expressed and secreted by subcutaneous adipose tissue (52) , while the expression of adiponectin, visfatin, omentin, resistin, PAI-1, IL-8, IL-7, IL-1a, MCP-1, TGF-b, growth-related oncogena, CCL5 and MIP-1b is higher in abdominal fat.”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [28]
In the citing paper
“In addition, the profile of adipokines produced is dissimilar between the subcutaneous and abdominal adipose tissues.”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [28]
Citations
Cites
Shock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
Insulin-like growth factors and their binding proteins
Sara, V. R., & Hall, K. E. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.3.591 · Cited by 923
Molecular Biology of Mammalian Glucose Transporters
Bell, G. I., Kayano, T., Buse, J. B., Burant, C. F., Takeda, J., Lin, D., Fukumoto, H., & Seino, S. (1990) · Diabetes Care · doi:10.2337/diacare.13.3.198 · Cited by 853
EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER
Balkwill, F. R., Burke, F., Talbot, D., Tavernier, J. H., Osborne, R. H., Naylor, S., Durbin, H., & Fiers, W. C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91850-2 · Cited by 417
Flores, E. A., Bistrian, B. R., Pomposelli, J. J., Dinarello, C. A., Blackburn, G. L., & Istfan, N. W. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114059 · Cited by 379
Mechanisms of Insulin Resistance Following Injury
Black, P. R., Brooks, D. C., Bessey, P. Q., Wolfe, R. R., & Wilmore, D. W. (1982) · Annals of Surgery · doi:10.1097/00000658-198210000-00005 · Cited by 376
Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings
MICHIE, H. R., Spriggs, D. R., Manogue, K. R., Sherman, M. L., Revhaug, A., O’Dwyer, S., Arthur, K. A., Dinarello, C. A., Cerami, A., & Wolff, S. M. (1989) · Journal of Critical Care · doi:10.1016/0883-9441(89)90142-1 · Cited by 356
Tumor necrosis factor in the pathophysiology of infection and sepsis
Fong, Y., & Lowry, S. F. (1990) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(90)90094-7 · Cited by 230
Contribution of different organs to increased glucose consumption after endotoxin administration.
Mészáros, K., Lang, C. H., Bagby, G. J., & Spitzer, J. J. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60912-3 · Cited by 153
Self-citationEffect of endotoxin-induced monokines on glucose metabolism in the muscle cell line L6.
Lee, M. D., Zentella‐Dehesa, A., Vine, W., Pekala, P. H., & Cerami, A. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.2590 · Cited by 133
Cited by
Sorted by citations
Items 201–300 of 534
Faheem, S. A., Saeed, N. M., El‐Naga, R. N., Ayoub, I. M., & Azab, S. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00218 · Cited by 62
Tumor necrosis factor–induced signal transduction and left ventricular remodeling
Mann, D. L. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.129253 · Cited by 62
The biological basis of malarial disease
Clark, I. A., Al-Yaman, F. M., & Jacobson, L. S. (1997) · International Journal for Parasitology · doi:10.1016/s0020-7519(97)00121-5 · Cited by 62
Seufert, J., Lübben, G., Dietrich, K., & BATES, P. C. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90125-7 · Cited by 62
The Risk of Developing Diabetes Mellitus in Patients with Psoriatic Arthritis: A Cohort Study
Eder, L., Chandran, V., Cook, R. J., & Gladman, D. D. (2017) · The Journal of Rheumatology · doi:10.3899/jrheum.160861 · Cited by 62
Park, J.-Y., Kim, Y.-H., Im, J. A., & Lee, H. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0709-1 · Cited by 58
Akoum, S. E., Lamontagne, V., Cloutier, I., & Tanguay, J. (2011) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-3-34 · Cited by 57
Visfatin levels and intima-media thicknesses in rheumatic diseases
Özgen, M., Koca, S. S., Aksoy, K., Dağlı, N., Üstündağ, B., & Işık, A. T. (2010) · Clinical Rheumatology · doi:10.1007/s10067-010-1649-2 · Cited by 55
Diabetes as a risk factor for periodontal disease: current status and future considerations.
Tan, W., Tay, F., & Lim, L. (2006) · Annals of the Academy of Medicine, Singapore · doi:10.47102/annals-acadmedsg.v35n8p571 · Cited by 63
Diabetes of Injury: Novel Insights
Vanhorebeek, I., & den Berghe, G. V. (2006) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2006.09.002 · Cited by 54
Nolte, L. A., Hansen, P. A., Chen, M. M., Schluter, J. M., Gulve, E. A., & Holloszy, J. O. (1998) · Diabetes · doi:10.2337/diabetes.47.5.721 · Cited by 52
Tumor necrosis factor‐α‐induced inflammatory responses in cattle
Kushibiki, S. (2011) · Animal Science Journal · doi:10.1111/j.1740-0929.2011.00931.x · Cited by 52
Geffner, M. E., Yeh, D. Y., Landaw, E. M., Scott, M. L., Stiehm, E. R., Bryson, Y. J., & Israele, V. (1993) · Pediatric Research · doi:10.1203/00006450-199307000-00016 · Cited by 51
Stress Insulin Resistance is a Marker for Mortality in Traumatic Brain Injury
Mowery, N. T., Gunter, O. L., Guillamondegui, O. M., Dossett, L. A., Dortch, M. J., Morris, J. A., & May, A. K. (2009) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3181938c5e · Cited by 50
Kumar, D. P., Santhekadur, P. K., Seneshaw, M., Mirshahi, F., Uram–Tuculescu, C., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.30346 · Cited by 50
Carter, E. A., Tompkins, R. G., Hsu, H., Christian, B., Alpert, N. M., Weise, S. B., & Fischman, A. J. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00355-x · Cited by 49
Filippin-Monteiro, F. B., de Oliveira, E. M., Sandri, S., Knebel, F. H., Albuquerque, R. C., & Čampa, A. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.193 · Cited by 49
Early events involved in the development of insulin resistance in Zucker fatty rat
Liu, R., Mizuta, M., Kurose, T., & Matsukura, S. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801924 · Cited by 48
Inflammation in Metabolic Syndrome and Type 2 Diabetes: Impact of Dietary Glucose
KEMPF, K., ROSE, B., HERDER, C., KLEOPHAS, U., MARTIN, S., & KOLB, H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.012 · Cited by 48
Gum, R. J., Gaede, L. L., Heindel, M. A., Waring, J. F., Trevillyan, J. M., Zinker, B. A., Stark, M. E., Wilcox, D. M., Jirousek, M. R., Rondinone, C. M., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0288 · Cited by 48
Kushibiki, S., HODATE, K., Shingu, H., Ueda, Y., SHINODA, M., Mori, Y., Itoh, T., & Yokomizo, Y. (2001) · Domestic Animal Endocrinology · doi:10.1016/s0739-7240(01)00102-3 · Cited by 49
Impairment of glucose metabolism in hearts from rats treated with endotoxin
Tessier, J. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00320-1 · Cited by 48
Turner, N. C., & Clapham, J. C. (1998) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8845-5_2 · Cited by 46
Tissue-specific regulation of IGF-I and IGF-binding proteins in response to TNFα
Lang, C. H., Nystrom, G. J., & Frost, R. A. (2001) · Growth Hormone & IGF Research · doi:10.1054/ghir.2001.0233 · Cited by 45
Self-citationBorst, S. E., Lee, Y., Conover, C. F., Shek, E. W., & Bagby, G. J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00054.2004 · Cited by 46
Self-citationThe Stress Axis in Obesity and Diabetes Mellitus: An Update
Gianotti, L., Belcastro, S., D’Agnano, S., & Tassone, F. (2021) · Endocrines · doi:10.3390/endocrines2030031 · Cited by 49
Tanrıkulu-Kılıç, F., Bekpınar, S., Ünlüçerçi, Y., & Orhan, Y. (2006) · Physiological Research · doi:10.33549/physiolres.930745 · Cited by 45
Morimoto, Y., Nishikawa, K., & Ohashi, M. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00561-4 · Cited by 45
Begum, N., Ragolia, L., & Srinivasan, M. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0214q.x · Cited by 45
Anabolic and anticatabolic agents in critical care
Stanojcic, M., Finnerty, C. C., & Jeschke, M. G. (2016) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000330 · Cited by 46
Germoush, M. O., Elgebaly, H. A., Hassan, S. M., Kamel, E. M., Bin-Jumah, M. N., & Mahmoud, A. M. (2019) · Antioxidants · doi:10.3390/antiox9010022 · Cited by 46
Elsayed, R. H., Kamel, E. M., Mahmoud, A. M., El‐Bassuony, A. A., Bin-Jumah, M. N., Lamsabhi, A. M., & Ahmed, S. A. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111202 · Cited by 47
Nutrient-induced insulin resistance
Proietto, J., Filippis, A., Nakhla, C., & Clark, S. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00050-7 · Cited by 42
Medina, E. A., Stanhope, K. L., Mizuno, T. M., Mobbs, C. V., Gregoire, F. M., Hubbard, N., Erickson, K., & Havel, P. J. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800970 · Cited by 43
How effective are lifestyle changes in the prevention of type 2 diabetes mellitus?
Pi-Sunyer, F. X. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00287.x · Cited by 40
TNF-α acutely upregulates amylin expression in murine pancreatic beta cells
Cai, K., Qi, D., Wang, O., Chen, J., Liu, X., Deng, B., Qian, L., Liu, X., & Le, Y. (2010) · Diabetologia · doi:10.1007/s00125-010-1972-9 · Cited by 42
Periodontal status and metabolic syndrome in middle-aged Japanese
福井, 尚. (2012) · Medical Entomology and Zoology · Cited by 42
Mammalian cell death proteases: A family of highly conserved aspartate specific cysteine proteases
Alnemri, E. S. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(199701)64:1 · Cited by 307
Major comorbid disease processes associated with increased incidence of acute kidney injury
Farooqi, S., & Dickhout, J. G. (2016) · World Journal of Nephrology · doi:10.5527/wjn.v5.i2.139 · Cited by 41
Insulin resistance and glucose-induced thermogenesis in critical illness
Carlson, G. (2001) · Proceedings of The Nutrition Society · doi:10.1079/pns200193 · Cited by 40
PEDF-induced alteration of metabolism leading to insulin resistance
Carnagarin, R., Dharmarajan, A., & Dass, C. R. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.11.006 · Cited by 41
Kristian, R. E. T. T. (1999) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.1999.0010s1008.x · Cited by 40
Najjar, S. M., & Russo, L. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0407-3 · Cited by 40
Sanchez, N. C. B., Young, T. R., Carroll, J. A., Corley, J. R., Rathmann, R. J., & Johnson, B. J. (2013) · Innate Immunity · doi:10.1177/1753425913482152 · Cited by 39
Schook, M. W., Wildt, D. E., Raghanti, M. A., Wolfe, B. A., & Dennis, P. M. (2015) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2015.05.003 · Cited by 39
Rosiglitazone improves glucose metabolism in nondiabetic uremic patients on CAPD
Lin, S., Lin, Y., Kuo, S., Hsu, Y., & Hung, Y.-J. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00844-8 · Cited by 39
Profile of patients with psoriasis associated with hepatitis C virus infection
Imafuku, S., & NAKAYAMA, J. (2013) · The Journal of Dermatology · doi:10.1111/1346-8138.12112 · Cited by 38
Duggan, E. W., Klopman, M. A., Berry, A. J., & Umpierrez, G. E. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0720-z · Cited by 39
Glucose dysmetabolism and prognosis in critical illness
Lazzeri, C., Tarquini, R., Giunta, F., & Gensini, G. F. (2008) · Internal and Emergency Medicine · doi:10.1007/s11739-008-0206-3 · Cited by 38
Vecchione, G., Grasselli, E., Cioffi, F., Baldini, F., Oliveira, P. J., Sardão, V. A., Cortese, K., Lanni, A., Voci, A., Portincasa, P., et al. (2017) · Frontiers in Nutrition · doi:10.3389/fnut.2017.00042 · Cited by 37
Lee, S. J., Kang, J. S., Kim, H. M., Lee, E. Y., Lee, J.-H., Chung, C. H., & Lee, E. Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222352 · Cited by 37
Heber, D., Byerley, L. O., & Tchekmedyian, N. S. (1992) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719201600605 · Cited by 37
Role of cytokines in AIDS wasting
Chang, H. R., Dulloo, A. G., & Bistrian, B. R. (1998) · Nutrition · doi:10.1016/s0899-9007(98)00108-7 · Cited by 35
Fontaine‐Bisson, B., Wolever, T. M. S., Chiasson, J., RABASA-LHORET, R. P. R., Maheux, P., Josse, R. G., Leiter, L. A., Rodger, N. W., Ryan, E. A., & El‐Sohemy, A. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.013 · Cited by 36
Liu, R., Kurose, T., & Matsukura, S. (2001) · Metabolism · doi:10.1053/meta.2001.19436 · Cited by 36
Relationship Between Adiposity and Cardiovascular Risk Factors in Prevalent Hemodialysis Patients
Kaysen, G. A., Kotanko, P., Zhu, F., Sarkar, S. R., Heymsfield, S. B., Kuhlmann, M. K., Dwyer, T., Usvyat, L. A., Havel, P. J., & Levin, N. W. (2009) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2009.04.002 · Cited by 36
Borst, S. E., & Bagby, G. J. (2002) · Metabolism · doi:10.1053/meta.2002.34043 · Cited by 36
Self-citationElsammak, M., Refai, W., Elsawaf, A., Abdel-Fattah, I., Elatti, E. A., & Ghazal, A. A. E. R. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x38141 · Cited by 35
Li, Z., Srivastava, S., Yang, X., Mittal, S., Norton, P. R., Resau, J. H., Haab, B. B., & Chan, C. (2007) · BMC Systems Biology · doi:10.1186/1752-0509-1-21 · Cited by 35
Han, J., LianQuan, B., Liu, X., Zhang, F., Zhang, Y., & Yu, N. (2014) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.2013.13659 · Cited by 35
Nara, M., Kanda, T., Tsukui, S., Inukai, T., Shimomura, Y., Inoue, S., & Kobayashi, I. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00242-8 · Cited by 36
Tumor necrosis factor alpha stimulates gluconeogenesis from alanine in vivo
Blumberg, D., Hochwald, S. N., BURT, M. E., Donner, D. B., & Brennan, M. F. (1995) · Journal of Surgical Oncology · doi:10.1002/jso.2930590404 · Cited by 34
Tse, M. C. L., Herlea‐Pana, O., Brobst, D. E., Yang, X., Wood, J., Hu, X., Liu, Z., Lee, C. W., Zaw, A. M., Chow, B., et al. (2017) · Diabetes · doi:10.2337/db16-0270 · Cited by 33
Metabolic Management during Critical Illness: Glycemic Control in the ICU
Inzucchi, S. E., & Honiden, S. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1565253 · Cited by 33
Yang, C., Shiau, M., Lai, Y.-R., Ho, K.-T., Hsiao, C., Chen, C., Lo, Y., & Chang, Y.-H. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6923187 · Cited by 32
Al‐Amarat, W., Abukhalil, M. H., Althunibat, O. Y., Alfwuaires, M. A., Alnamshan, M. M., Alqosaibi, A. I., Ahmeda, A. F., Kamel, E. M., Arab, H. H., & Mahmoud, A. M. (2021) · Processes · doi:10.3390/pr9091562 · Cited by 31
REDD1 promotes obesity-induced metabolic dysfunction via atypical NF-κB activation
Lee, D., Kim, T., Byeon, J., Park, M., Kim, S., Kim, J., Choi, S., Lee, G., Park, C., Lee, K. W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34110-1 · Cited by 35
Fürnsinn, C., Neschen, S., Wagner, O. F., Roden, M., Bisschop, M., & Waldhäusl, W. K. (1997) · Endocrinology · doi:10.1210/endo.138.7.5219 · Cited by 31
Kim, O., Jun, W., & Lee, J. (2016) · Nutrients · doi:10.3390/nu8010060 · Cited by 31
IJzerman, R. G., Voordouw, J. J., van Weissenbruch, M. M., Yudkin, J. S., Serné, E. H., de Waal, H. A. D., & Stehouwer, C. D. A. (2006) · Clinical Science · doi:10.1042/cs20050314 · Cited by 31
GLP-1–Based Therapies Have No Microvascular Effects in Type 2 Diabetes Mellitus
Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., Diamant, M., Serné, E. H., & van Raalte, D. H. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307930 · Cited by 31
Sheu, W. H., Lee, W., Lin, L., Chang, R., & Chen, Y.-T. (2001) · Metabolism · doi:10.1053/meta.2001.27192 · Cited by 31
Kushibiki, S., HODATE, K., Shingu, H., Ueda, Y., Mori, Y., Itoh, T., & Yokomizo, Y. (2001) · American Journal of Veterinary Research · doi:10.2460/ajvr.2001.62.794 · Cited by 32
Abdominal obesity in BTBR male mice is associated with peripheral but not hepatic insulin resistance
Flowers, J. B., Oler, A. T., Nadler, S. T., Choi, Y., Schueler, K. L., Yandell, B. S., Kendziorski, C. M., & Attie, A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00370.2006 · Cited by 33
Ranganathan, S., & Davidson, M. B. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90007-4 · Cited by 31
Modulation of the hypermetabolic response after burn injury
Gauglitz, G. G., Finnerty, C. C., Herndon, D. N., Williams, F. N., & Jeschke, M. G. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2786-9.00030-8 · Cited by 31
Limone, P. P. (2003) · Journal of Infection · doi:10.1016/s0163-4453(03)00055-0 · Cited by 30
Naitoh, T., Kitahara, M., & Tsuruzoe, N. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00152-8 · Cited by 32
Nagamatsu, S., Nakamichi, Y., Ohara‐Imaizumi, M., Ozawa, S., Katahira, H., Watanabe, T., & Ishida, H. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03146-5 · Cited by 31
(ESC), G. D. T. S. D. Y. E. C. D. L. S. E. D. C., & (EASD), D. L. S. E. P. E. E. D. L. D. (2007) · Revista Española de Cardiología · doi:10.1016/s0300-8932(07)75070-4 · Cited by 28
Bouter, B., Geary, N., Langhans, W., & Asarian, L. (2010) · Metabolism · doi:10.1016/j.metabol.2009.11.003 · Cited by 29
Hozayen, W. G., Mahmoud, A. M., Soliman, H., & Mostafa, S. (2016) · Journal of Intercultural Ethnopharmacology · doi:10.5455/jice.20151230055930 · Cited by 29
Gupta, D., & Khandelwal, R. L. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.01.003 · Cited by 29
Interleukin-4 Promotes Myogenesis and Boosts Myocyte Insulin Efficacy
Chang, Y.-H., Tsai, J., Chen, T.-L., Ho, K.-T., Cheng, H. K., Hsiao, C., & Shiau, M. (2019) · Mediators of Inflammation · doi:10.1155/2019/4182015 · Cited by 28
Abduh, M. S., Alzoghaibi, M. A., Alzoghaibi, A. M., Bin‐Ammar, A., Alotaibi, M., Kamel, E. M., & Mahmoud, A. M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121612 · Cited by 29
Lipid metabolism in tumour-bearing mice:
López‐Soriano, J., Llovera, M., Carbó, N., Garcia‐Martínez, C., López-Soriano, F. J., & Argilés, J. M. A. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00125-1 · Cited by 28
Grohmann, M. J., Foulstone, E. J., Welsh, G. I., Holly, J. M. P., Hamilton-Shield, J. P., Crowne, E. C., & Stewart, C. E. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.093906 · Cited by 29
Jonk, A. M., Houben, A. J. H. M., Schaper, N. C., de Leeuw, P. W., Serné, E. H., Smulders, Y. M., & Stehouwer, C. D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2587 · Cited by 28
Lang, C. H., Derdák, Z., & Wands, J. R. (2014) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12343 · Cited by 27
Self-citationTakano, M., Nishihara, R., Sugano, N., Matsumoto, K., Yamada, Y., Takane, M., Fujisaki, Y., & Ito, K. (2010) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2010.03.004 · Cited by 27
de Boer, M. P., Meijer, R. I., Newman, J., Stehouwer, C. D. A., Eringa, E. C., Smulders, Y. M., & Serné, E. H. (2014) · Microcirculation · doi:10.1111/micc.12114 · Cited by 27
Tanaka, S., Isoda, F., Kiuchi, Y., Ikeda, H., Mobbs, C. V., & Yamakawa, T. (2000) · Metabolism · doi:10.1053/meta.2000.9516 · Cited by 27
Endocrine interventions in the ICU.
Ellger, B., Debaveye, Y., & den Berghe, G. V. (2005) · European journal of internal medicine · doi:10.1016/j.ejim.2004.10.014 · Cited by 26
Lang, C. H., Nystrom, G. J., & Frost, R. A. (2008) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/01.ta.0000249375.43015.01 · Cited by 26
Self-citationLeptin and the Adipocyte Endocrine System
Diamond, F., & Eichler, D. C. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360290795565 · Cited by 27
Mizuta, T., Kawaguchi, Y., Eguchi, Y., Takahashi, K., Ario, K., Akiyama, T., Oza, N., Otsuka, T., Kuwashiro, T., Yoshimura, T., et al. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-008-0691-2 · Cited by 25
Merz, T. M., & Finfer, S. R. (2008) · Critical Care · doi:10.1186/cc6837 · Cited by 24
Vanhorebeek, I., Langouche, L., & den Berghe, G. V. (2006) · Endocrine Practice · doi:10.4158/ep.12.s3.14 · Cited by 25
Malaria, blood glucose, and the role of tumour necrosis factor (TNF) in mice
Elased, K. M., Taverne, J., & Playfair, J. H. L. (1996) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-781.x · Cited by 25
Nicchio, I. G., Cirelli, T., Quil, L. C. D. C., Camilli, Â. C., Scarel‐Caminaga, R. M., & Leite, F. R. M. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116908 · Cited by 28
Metadata
- Authors
- Lang, C. H., Dobrescu, C., & Bagby, G. J.
- Affiliations
- Louisiana State University (US)
- ORCID
- Lang, C H
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1992-01
- Volume
- 130
- Issue
- 1
- Pages
- 43-52
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2067057146
- Cited by
- 535
- References
- 31
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 7 · 2023: 2 · 2022: 9 · 2021: 10 · 2020: 8 · 2019: 7 · 2018: 9 · 2017: 13 · 2016: 15 · 2015: 11 · 2014: 18 · 2013: 24 · 2012: 17
- FWCI
- 9.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01gm032654-10)
- National Institute of General Medical Sciences (GM 32654, GM 38032)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- TNF-α, insulin resistance, hepatic glucose production, hyperinsulinemic-euglycemic clamp, glucose uptake, muscle glucose uptake, whole-body glucose metabolism
- MeSH terms
- Animals, Glucose, Insulin Antagonists, Insulin Resistance, Liver, Male, Rats, Inbred Strains, Tumor Necrosis Factor-alpha, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review